Letter to the Editor: How Should We Treat High-risk Patients in the Chronic Phase Following PCI: Clopidogrel or Prolonged DAPT?
10.3346/jkms.2021.36.e167
- Author:
Hao-Yu WANG
1
;
Ke-Fei DOU
Author Information
1. Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
- Publication Type:Correspondence
- From:Journal of Korean Medical Science
2021;36(22):e167-
- CountryRepublic of Korea
- Language:English
